Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2818-2829
Published online before print November 26, 2007, doi: 10.1161/CIRCULATIONAHA.107.715847
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
116/24/2818    most recent
CIRCULATIONAHA.107.715847v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, E. I.
Right arrow Articles by Gurtner, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, E. I.
Right arrow Articles by Gurtner, G. C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Bone Marrow Transplantation
*Stem Cells
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Ischemic biology - basic studies

(Circulation. 2007;116:2818-2829.)
© 2007 American Heart Association, Inc.


Molecular Cardiology

Age Decreases Endothelial Progenitor Cell Recruitment Through Decreases in Hypoxia-Inducible Factor 1{alpha} Stabilization During Ischemia

Eric I. Chang, MD*; Shang A. Loh, MD*; Daniel J. Ceradini, MD; Edward I. Chang, MD; Shin-e Lin, MD; Nicholas Bastidas, MD; Shahram Aarabi, MD; Denise A. Chan, PhD; Michael L. Freedman, MD; Amato J. Giaccia, PhD; Geoffrey C. Gurtner, MD

From the Department of Surgery (Eric I. Chang, S.A.L., D.J.C., Edward I. Chang, S.L., N.B., S.A., G.C.G.) and Department of Radiation Biology (D.A.C., A.J.G.), Stanford University, Stanford, Calif; and Department of Medicine (M.L.F.), New York University, New York, NY.

Correspondence to Geoffrey C. Gurtner, MD, Stanford University, PSRL–GK201, 257 Campus Dr, Stanford, CA 94305-5148. E-mail ggurtner{at}stanford.edu

Received May 16, 2007; accepted September 28, 2007.

Background— Advanced age is known to impair neovascularization. Because endothelial progenitor cells (EPCs) participate in this process, we examined the effects of aging on EPC recruitment and vascular incorporation.

Methods and Results— Murine neovascularization was examined by use of an ischemic flap model, which demonstrated aged mice (19 to 24 months) had decreased EPC mobilization (percent mobilized 1.4±0.2% versus 0.4±0.1%, P<0.005) that resulted in impaired gross tissue survival compared with young mice (2 to 6 months). This decrease correlated with diminished tissue perfusion (P<0.005) and decreased CD31+ vascular density (P<0.005). Gender-mismatched bone marrow transplantation demonstrated significantly fewer chimeric vessels in aged mice (P<0.05), which confirmed a deficit in bone marrow–mediated vasculogenesis. Age had no effect on total EPC number in mice or humans. Reciprocal bone marrow transplantations confirmed that impaired neovascularization resulted from defects in the response of aged tissue to hypoxia and not from intrinsic defects in EPC function. We demonstrate that aging decreased hypoxia-inducible factor 1{alpha} stabilization in ischemic tissues because of increased prolyl hydroxylase–mediated hydroxylation (P<0.05) and proteasomal degradation. This resulted in a diminished hypoxia response, including decreased stromal cell–derived factor 1 (P<0.005) and vascular endothelial growth factor (P<0.0004). This effect can be reversed with the iron chelator deferoxamine, which results in hypoxia-inducible factor 1{alpha} stabilization and increased tissue survival.

Conclusions— Aging impairs EPC trafficking to sites of ischemia through a failure of aged tissues to normally activate the hypoxia-inducible factor 1{alpha}–mediated hypoxia response.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Circ. Res.Home page
S. Dimmeler and A. Leri
Aging and Disease as Modifiers of Efficacy of Cell Therapy
Circ. Res., June 6, 2008; 102(11): 1319 - 1330.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Schmitt and L. G. Cantley
The impact of aging on kidney repair
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1265 - F1272.
[Abstract] [Full Text] [PDF]